survodutide vs tirzepatide vs retatrutide Triple Agonism Based Therapies for Obesity Retatrutide vs Tirzepatide (2026): Differences

However, some insurance plans require referrals for coverage, and certain specialty clinics within health systems may prefer referrals for coordination of care

Researchers are thus advised to follow best practices when administering epithalon and rotate injection sites to lessen the risk of injection-related side effects

Teng C, Jia J, Wang Z, Sharma VK, Yan B

Lin X, Li H

MAXIMUM RESULTS Starting at $250/month Targets BOTH GLP-1 and GIP receptors Average 2022% body weight loss (SURMOUNT trial data) Once-weekly subcutaneous injection Stronger insulin sensitivity benefit Often greater appetite suppression Compounded by licensed 503A pharmacy Patients seeking maximum weight loss results, those with insulin resistance or pre-diabetes, or anyone who didn't respond optimally to semaglutide alone

This study is the first to evaluate the weight loss effect of this medication exclusively in patients with Type 2 diabetes